Polianta Ltd’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-43,500
Closed -$1.13M 101
2023
Q1
$1.13M Buy
43,500
+20,800
+92% +$557K 0.52% 45
2022
Q4
$536K Sell
22,700
-400
-2% -$10.8K 0.4% 69
2022
Q3
$585K Buy
23,100
+5,700
+33% +$200K 0.48% 47
2022
Q2
$577K Buy
+17,400
New +$739K 0.49% 53
2021
Q3
Sell
-8,200
Closed -$1.36M 96
2021
Q2
$1.36M Buy
+8,200
New +$1.33M 0.71% 11

Other funds holding TDOC

Polianta Ltd's TDOC Position: Q2 2023 in Review

Polianta Ltd sold out of Teladoc Health (TDOC) in Q2 2023, closing a stake of 43,500 shares — an estimated $1.13M sold.

Polianta Ltd first reported a position in TDOC in Q2 2021 and held it in 5 quarters. The position peaked at $1.36M in Q2 2021. 431 funds tracked by Wall St. Rank hold TDOC as of Q2 2023.

  • Polianta Ltd reported no remaining Teladoc Health position as of Q2 2023 after selling out during the quarter.
  • Polianta Ltd sold 43,500 Teladoc Health shares in Q2 2023, an estimated $1.13M.
  • Polianta Ltd first reported a position in Teladoc Health in Q2 2021 and held it in 5 quarters.
  • Polianta Ltd's Teladoc Health position peaked at $1.36M in Q2 2021.
  • 431 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2023.

Based on Polianta Ltd's 13F filing for Q2 2023, filed 19 Jul 2023.